SCBIO
Latest round
- Series A
Last raised
- May 2023
Total raised
- $8.3M
Investors
- 9
About SCBIO
Founded in 2021, and based in Daejeon, South Korea, SCBIO Inc. operates as a biotechnology company that is involved in the research on cancer-related diseases with the goal of developing anticancer drugs. In August 2022, SCBIO Inc. In May 2023, SCBIO Inc.S. The firm develops low-molecular compound immunotherapy drugs namely SCB001 and SCB002 that regulate immune cell activity in tumors to produce anti-cancer efficacy, and is especially helpful in treating pancreatic cancer.
Who invested in SCBIO
9 investors across 1 round
See all investors in SCBIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 18, 2023
Amount
$8.3M
Investors
Questions about SCBIO
Who invested in SCBIO?
SCBIO has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SCBIO raised?
SCBIO has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SCBIO last raise money?
SCBIO's most recent round on record is a Series A, in May 2023.
What does SCBIO do?
Founded in 2021, and based in Daejeon, South Korea, SCBIO Inc.
Where is SCBIO headquartered?
SCBIO is headquartered in Daejeon, South Korea.
Which VCs invest in companies like SCBIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at SCBIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SCBIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.